JOHN R. WALSH, M.D.; FRED L. HUMOLLER, Ph.D.; FREDERICK G. GILLICK, M.D., F.A.C.P.
In 1954 LaDue and collaborators1 reported on the value of the serum transaminase (SGO-T) level as a diagnostic measure for acute myocardial infarction. Since that time this test has become as popular as the electrocardiogram in studies of patients suspected of this disorder. Elevations of the SGO-T have been found in a high percentage of patients with acute myocardial infarction.2-4 It was anticipated that this test would provide a method for differentiating myocardial infarction from disorders simulating it, such as pancreatitis, pulmonary infarction and coronary insufficiency. However, subsequent studies have indicated that the SGO-T test is less specific than was
JOHN R. WALSH, FRED L. HUMOLLER, FREDERICK G. GILLICK. SERUM TRANSAMINASE IN PULMONARY DISEASE AND MULTIPLE INFARCTIONS(SERUM TRANSAMINASE IN PULMONARY DISEASE AND MULTIPLE INFARCTIONS*). Ann Intern Med. 1957;46:1105–1112. doi: 10.7326/0003-4819-46-6-1105
Download citation file:
Published: Ann Intern Med. 1957;46(6):1105-1112.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use